Literature DB >> 16724273

"Social separation" among women under 40 years of age diagnosed with breast cancer and carrying a BRCA1 or BRCA2 mutation.

Regina Kenen1, Audrey Ardern-Jones, Rosalind Eeles.   

Abstract

We conducted an exploratory, qualitative study investigating experiences of women who had developed breast cancer under the age of 40 and who were identified as BRCA1 or BRCA2 mutation carriers. These germline mutation carriers face an increased lifetime risk of a second primary breast cancer and an increased risk for a primary ovarian cancer. Thirteen women who fit this criteria participated in three focus groups conducted at a major cancer center in the UK during Spring 2003. We asked broad, open-ended questions that allowed for a wide range of responses about their cancer and genetic testing experiences, physical and psycho-social concerns, family and partner reactions and their need for social support. The women expressed feelings of devastation, loneliness, feeling different and isolation, ambivalence about having to support family members, worries about partner's anxiety and depression, and anxiety about talking to family members, especially children. These feelings were stronger after the cancer diagnosis and compounded by the genetic test results that occurred at a later time. We also found that, at least temporarily, the women experienced what we call "social separation"--emotional distance from, or dissonance with groups they interact with or are part of, e.g., family and friends, frequently leading to a reduction in communication or a change in previously unstated, but accepted normal interaction. We concentrate on a few characteristics of social separation-feelings of aloneness, isolation and separation, use of silence and verbal discretion, the relationship between estrangement and kinship interaction and norm disruption, and are looking at social patterns of interpersonal relationships that may occur when risk and illness statuses are new and framing and feeling rules have not as yet been clearly developed due to a cultural lag.

Entities:  

Mesh:

Year:  2006        PMID: 16724273     DOI: 10.1007/s10897-005-9015-2

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  18 in total

1.  Nuance, complexity, and context: qualitative methods in genetic counseling research.

Authors:  Diane Beeson
Journal:  J Genet Couns       Date:  1997-03       Impact factor: 2.537

Review 2.  The effectiveness of family interventions for physical disorders.

Authors:  Thomas L Campbell
Journal:  J Marital Fam Ther       Date:  2003-04

3.  Disclosing genetic test results to family members.

Authors:  Rebekah J Hamilton; Barbara J Bowers; Janet K Williams
Journal:  J Nurs Scholarsh       Date:  2005       Impact factor: 3.176

4.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Authors:  J P Struewing; P Hartge; S Wacholder; S M Baker; M Berlin; M McAdams; M M Timmerman; L C Brody; M A Tucker
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

5.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

6.  Understanding the experience of prophylactic bilateral mastectomy: a qualitative study of ten women.

Authors:  S M Lloyd; M Watson; G Oaker; N Sacks; U Querci della Rovere; G Gui
Journal:  Psychooncology       Date:  2000 Nov-Dec       Impact factor: 3.894

7.  Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

Authors:  D Thompson; D Easton
Journal:  Am J Hum Genet       Date:  2001-01-19       Impact factor: 11.025

8.  Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

Authors:  José Palacios; Emiliano Honrado; Ana Osorio; Alicia Cazorla; David Sarrió; Alicia Barroso; Sandra Rodríguez; Juan C Cigudosa; Orland Diez; Carmen Alonso; Enrique Lerma; Lydia Sánchez; Carmen Rivas; Javier Benítez
Journal:  Clin Cancer Res       Date:  2003-09-01       Impact factor: 12.531

9.  We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC).

Authors:  Regina Kenen; Audrey Arden-Jones; Rosalind Eeles
Journal:  Psychooncology       Date:  2004-05       Impact factor: 3.894

10.  BRCA1 and BRCA2 as ovarian cancer susceptibility genes.

Authors:  Heidi M Sowter; Alan Ashworth
Journal:  Carcinogenesis       Date:  2005-05-25       Impact factor: 4.944

View more
  13 in total

Review 1.  Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.

Authors:  Susanne B Haga; Rachel Mills; Hayden Bosworth
Journal:  Patient Educ Couns       Date:  2014-06-21

2.  Can self-esteem, mastery and perceived stigma predict long-term adjustment in women carrying a BRCA1/2-mutation? Evidence from a multi-center study.

Authors:  Andrea Vodermaier; Mary Jane Esplen; Christine Maheu
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

Review 3.  What facilitates or impedes family communication following genetic testing for cancer risk? A systematic review and meta-synthesis of primary qualitative research.

Authors:  Kim Chivers Seymour; Julia Addington-Hall; Anneke M Lucassen; Claire L Foster
Journal:  J Genet Couns       Date:  2010-04-09       Impact factor: 2.537

4.  Exploration of Male Attitudes on Partnerships and Sexuality with Female BRCA1/2 Mutation Carriers.

Authors:  Caitlin Mauer; Sara Spencer; Jeffery Dungan; Karen Hurley
Journal:  J Genet Couns       Date:  2015-08-08       Impact factor: 2.537

5.  Living With Genetic Vulnerability: a Life Course Perspective.

Authors:  Rebekah J Hamilton; Nancy A Innella; Dawn T Bounds
Journal:  J Genet Couns       Date:  2015-09-02       Impact factor: 2.537

6.  Sisters in hereditary breast and ovarian cancer families: communal coping, social integration, and psychological well-being.

Authors:  Laura M Koehly; June A Peters; Natalia Kuhn; Lindsey Hoskins; Anne Letocha; Regina Kenen; Jennifer Loud; Mark H Greene
Journal:  Psychooncology       Date:  2008-08       Impact factor: 3.894

7.  The effect of BRCA gene testing on family relationships: A thematic analysis of qualitative interviews.

Authors:  Heather A Douglas; Rebekah J Hamilton; Robin E Grubs
Journal:  J Genet Couns       Date:  2009-05-29       Impact factor: 2.537

8.  A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25.

Authors:  Lindsey M Hoskins; Allison Werner-Lin
Journal:  J Genet Couns       Date:  2012-08-03       Impact factor: 2.537

Review 9.  Genetics: breast cancer as an exemplar.

Authors:  Rebekah Hamilton
Journal:  Nurs Clin North Am       Date:  2009-09       Impact factor: 1.208

Review 10.  Survivorship considerations in adults with hereditary breast and ovarian cancer syndrome: state of the science.

Authors:  Cheryl B Crotser; Marcia Boehmke
Journal:  J Cancer Surviv       Date:  2009-01-23       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.